MONROVIA, Calif., Nov. 21, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that Barry Caldwell, President and CEO, and Steve Brown, CFO, will participate in a fireside chat at the 25th Annual Piper Jaffray Healthcare Conference at the New York Palace Hotel on Tuesday, December 3at 3:00 p.m. ET.
STAAR will offer a live audio webcast of its presentation on the Company’s website, www.staar.com, under Investor Information. An archived replay of the presentation will be available for 90 days, also at www.staar.com.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or “ICL.” A lens used to replace the natural lens after cataract surgery is called an intraocular lens or “IOL.” Over 375,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company’s website at www.staar.com.
Collamer® is the registered trademark for STAAR’s proprietary biocompatible collagen copolymer lens material.
CONTACT: | Investors | Media |
EVC Group | EVC Group | |
Doug Sherk, 415-652-9100 | Janine McCargo | |
Leigh Salvo, 415-568-9348 | 646-688-0425 |
SOURCE STAAR Surgical Company
Help employers find you! Check out all the jobs and post your resume.
